Inside AHA’s Late-Breaking Lipid Trials: The Rise of Oral PCSK9 Inhibition

Season 1 Episode 20  ·  Nov 18, 2025, 02:00 PM
Headliner
Share
Subscribe
This week, host Craig Beavers spoke with Joe Sassine, PharmD, BCPS, BCACP, CLS, about several key trials presented at the American Heart Association 2025 Scientific Sessions.

Show notes:
Share
Subscribe
Next
Breaking Down Celebrate and POLY-HF: Two Paths to Better Cardiac Care
Top episodes
COBRRA Trial Results Raise Questions About VTE Management
by The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
New Dyslipidemia Guidelines Restore LDL Goals and Expand Pharmacist Opportunities
by The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
Everything You Need to Know from the American College of Cardiology 2025 Scientific Session
by The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest